Identification of Sphingolipid Metabolites That Induce Obesity via Misregulation of Appetite, Caloric Intake and Fat Storage in

English version České info

Obesity is defined by excessive lipid accumulation. However, the active mechanistic roles that lipids play in its progression are not understood. Accumulation of ceramide, the metabolic hub of sphingolipid metabolism, has been associated with metabolic syndrome and obesity in humans and model systems. Here, we use Drosophila genetic manipulations to cause accumulation or depletion of ceramide and sphingosine-1-phosphate (S1P) intermediates. Sphingolipidomic profiles were characterized across mutants for various sphingolipid metabolic genes using liquid chromatography electrospray ionization tandem mass spectroscopy. Biochemical assays and microscopy were used to assess classic hallmarks of obesity including elevated fat stores, increased body weight, resistance to starvation induced death, increased adiposity, and fat cell hypertrophy. Multiple behavioral assays were used to assess appetite, caloric intake, meal size and meal frequency. Additionally, we utilized DNA microarrays to profile differential gene expression between these flies, which mapped to changes in lipid metabolic pathways. Our results show that accumulation of ceramides is sufficient to induce obesity phenotypes by two distinct mechanisms: 1) Dihydroceramide (C_14:0) and ceramide diene (C_14:2) accumulation lowered fat store mobilization by reducing adipokinetic hormone- producing cell functionality and 2) Modulating the S1P: ceramide (C_14:1) ratio suppressed postprandial satiety via the hindgut-specific neuropeptide like receptor dNepYr, resulting in caloric intake-dependent obesity.

Vyšlo v časopise: Identification of Sphingolipid Metabolites That Induce Obesity via Misregulation of Appetite, Caloric Intake and Fat Storage in. PLoS Genet 9(12): e32767. doi:10.1371/journal.pgen.1003970
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1003970

Souhrn

Zdroje

1. El AlwaniM, WuBX, ObeidLM, HannunYA (2006) Bioactive sphingolipids in the modulation of the inflammatory response. Pharmacol Ther 112: 171–183.

2. PatwardhanGA, LiuYY (2011) Sphingolipids and expression regulation of genes in cancer. Prog Lipid Res 50: 104–114.

3. JarvisWD, GrantS (1998) The role of ceramide in the cellular response to cytotoxic agents. Curr Opin Oncol 10: 552–559.

4. HannunYA, ObeidLM (2008) Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol 9: 139–150.

5. HollandWL, SummersSA (2008) Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism. Endocr Rev 29: 381–402.

6. SamadF, HesterKD, YangG, HannunYA, BielawskiJ (2006) Altered adipose and plasma sphingolipid metabolism in obesity: a potential mechanism for cardiovascular and metabolic risk. Diabetes 55: 2579–2587.

7. YangG, BadeanlouL, BielawskiJ, RobertsAJ, HannunYA, et al. (2009) Central role of ceramide biosynthesis in body weight regulation, energy metabolism, and the metabolic syndrome. Am J Physiol Endocrinol Metab 297: E211–224.

8. HerrDR, FyrstH, PhanV, HeineckeK, GeorgesR, et al. (2003) Sply regulation of sphingolipid signaling molecules is essential for Drosophila development. Development 130: 2443–2453.

9. LeeKS, YouKH, ChooJK, HanYM, YuK (2004) Drosophila short neuropeptide F regulates food intake and body size. J Biol Chem 279: 50781–50789.

10. JaWW, CarvalhoGB, MakEM, de la RosaNN, FangAY, et al. (2007) Prandiology of Drosophila and the CAFE assay. Proc Natl Acad Sci U S A 104: 8253–8256.

11. FyrstH, ZhangX, HerrDR, ByunHS, BittmanR, et al. (2008) Identification and characterization by electrospray mass spectrometry of endogenous Drosophila sphingadienes. J Lipid Res 49: 597–606.

12. GronkeS, MullerG, HirschJ, FellertS, AndreouA, et al. (2007) Dual lipolytic control of body fat storage and mobilization in Drosophila. PLoS Biol 5: e137.

13. McQuiltonP, St PierreSE, ThurmondJ, FlyBaseC (2012) FlyBase 101–the basics of navigating FlyBase. Nucleic Acids Res 40: D706–714.

14. ChintapalliVR, WangJ, DowJA (2007) Using FlyAtlas to identify better Drosophila melanogaster models of human disease. Nat Genet 39: 715–720.

15. ParkerE, Van HeekM, StamfordA (2002) Neuropeptide Y receptors as targets for anti-obesity drug development: perspective and current status. Eur J Pharmacol 440: 173–187.

16. GraveleyBR, BrooksAN, CarlsonJW, DuffMO, LandolinJM, et al. (2011) The developmental transcriptome of Drosophila melanogaster. Nature 471: 473–479.

17. IdaT, TakahashiT, TominagaH, SatoT, KumeK, et al. (2011) Identification of the novel bioactive peptides dRYamide-1 and dRYamide-2, ligands for a neuropeptide Y-like receptor in Drosophila. Biochem Biophys Res Commun 410: 872–877.

18. BrinkmannV, DavisMD, HeiseCE, AlbertR, CottensS, et al. (2002) The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J Biol Chem 277: 21453–21457.

19. McCampbellA, TruongD, BroomDC, AllchorneA, GableK, et al. (2005) Mutant SPTLC1 dominantly inhibits serine palmitoyltransferase activity in vivo and confers an age-dependent neuropathy. Hum Mol Genet 14: 3507–3521.

20. BauerR, VoelzmannA, BreidenB, SchepersU, FarwanahH, et al. (2009) Schlank, a member of the ceramide synthase family controls growth and body fat in Drosophila. EMBO J 28: 3706–3716.

21. HollandWL, BrozinickJT, WangLP, HawkinsED, SargentKM, et al. (2007) Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. Cell Metab 5: 167–179.

22. FabriasG, Munoz-OlayaJ, CingolaniF, SignorelliP, CasasJ, et al. (2012) Dihydroceramide desaturase and dihydrosphingolipids: debutant players in the sphingolipid arena. Prog Lipid Res 51: 82–94.

23. MizugishiK, YamashitaT, OliveraA, MillerGF, SpiegelS, et al. (2005) Essential role for sphingosine kinases in neural and vascular development. Mol Cell Biol 25: 11113–11121.

24. NiralaNK, RahmanM, WallsSM, SinghA, ZhuLJ, et al. (2013) Survival response to increased ceramide involves metabolic adaptation through novel regulators of glycolysis and lipolysis. PLoS Genet 9: e1003556.

25. KuhnleinRP (2010) Energy homeostasis regulation in Drosophila: a lipocentric perspective. Results Probl Cell Differ 52: 159–173.

26. FutermanAH, RiezmanH (2005) The ins and outs of sphingolipid synthesis. Trends Cell Biol 15: 312–318.

27. MerrillAHJr, SullardsMC, AllegoodJC, KellyS, WangE (2005) Sphingolipidomics: high-throughput, structure-specific, and quantitative analysis of sphingolipids by liquid chromatography tandem mass spectrometry. Methods 36: 207–224.

28. GronkeS, MildnerA, FellertS, TennagelsN, PetryS, et al. (2005) Brummer lipase is an evolutionary conserved fat storage regulator in Drosophila. Cell Metab 1: 323–330.